Abbott will gain access to Huya’s Chinese bioscience network comprising premier companies, universities, government research institutions and bioparks throughout the country. Huya said that it has agreements in
The three purchasers were two existing investors in the company, Venrock Associates (which is affiliated with Anthony Evnin, a director of the company) and New Enterprise Associates (which
Swiss biopharmaceutical company Actelion has reported a net income of CHF102.1m, or CHF0.83 per diluted share, for the first quarter of 2009, compared to CHF44.5m, or CHF0.36 per
Together, the platforms enable researchers to effectively study the entire genome for epigenetic interactions between DNA and DNA-binding proteins to determine regions of the genome that are transcriptionally
QRxPharma, a specialty pharmaceutical company, has successfully completed a Phase III program pilot study comparing the efficacy and safety profile of MoxDuo IR against component doses of morphine
Concurrent with the signing of the agreement, Bradley Somer will serve as Bio-Path’s medical officer and medical liaison for the conduct of the company’s upcoming Phase I clinical
BioAlliance Pharma said that plasmid AMEP displays anti-angiogenic and anti-metastatic properties. Results presented describe the anti-angiogenic and anti-tumoral properties of the plasmid AMEP biotherapy in in vitro and
Peregrine Pharmaceuticals, a biopharmaceutical company, has reported that updated preliminary data from the initial cohort of 21 patients in its Phase II trial evaluating bavituximab in combination with
PPD will provide clinical management services in key therapeutic areas from this new location in Japan. The office strengthens PPD’s operations in the country, where it has worked
Boston Scientific, a developer and marketer of medical devices, has reported a net loss of $13m, or $0.01 per diluted share, for the first quarter of 2009, compared
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.